Showing results (91-100 of 110) with videos related to
Sort By:
Pageof 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assayG Curigliano, M Colleoni, G Renne, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyE Montagna, V Bagnardi, G Viale, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institutionO Gentilini, E Botteri, N Rotmensz, et al.Ecancermedicalscience|January 26, 2012
Full-dose intra-operative radiotherapy with electrons (ELIOT) during breast-conserving surgery: experience with 1246 casesU Veronesi, R Orecchia, A Luini, et al.Critical Reviews in Oncology/Hematology|November 23, 2006
Early detection of cancer: ideas for a debateR Gennari, U Veronesi, C Andreoli, et al.Breast Cancer Research and Treatment|June 30, 2009
Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedureE Montagna, G Viale, N Rotmensz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2011
Breast cancer subtypes and outcome after local and regional relapseE Montagna, V Bagnardi, N Rotmensz, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Outcome of special types of luminal breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)F Nolè, I Minchella, M Colleoni, et al.Breast Cancer Research and Treatment|April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypesG Cancello, P Maisonneuve, N Rotmensz, et al.Pageof 11